Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex

Journal of Biomaterials Science, Polymer Edition

Volumn 22, Issue 11, 2011, Pages 1487-1507

  Chiu, Chien Chih ^a   Lin, Yin Tzu ^a   Sun, Shuo Li ^a   Sung, Kuo Hsun ^a   Wang, Li Fang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

chitosan; Chondroitin sulfate; doxorubicin; folate receptor; folic acid; polyelectrolyte complexation

Indexed keywords

BINDING ENERGY; CHITOSAN; CYTOLOGY; FLUORESCENCE; ORGANIC ACIDS; POLYELECTROLYTES; SULFUR COMPOUNDS; TUMORS;

CHONDROITIN SULFATES; DOXORUBICIN; FOLATE RECEPTOR; FOLIC ACIDS; POLYELECTROLYTE COMPLEXATION;

CELLS;

CHITOSAN; CHONDROITIN SULFATE; DOXORUBICIN; FLUORESCENT DYE; FOLIC ACID; NANOPARTICLE; POLYELECTROLYTE; POLYMER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN KB; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; INTERNALIZATION; PRIORITY JOURNAL;

EID: 79955156117     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050610X512414     Document Type: Article

References (42)

1. K. A. Janes, M. P. Fresneau, A. Marazuela, A. Fabra and M. J. Alonso, J. Control. Rel. 73, 255 (2001).
2. Y. Zheng,W. Yang, C.Wang, J. Hu, S. Fu, L. Dong, L.Wu and X. Shen, Eur. J. Pharm. Biopharm. 67, 621 (2007).
3. A. Jain, Y. Gupta and S. K. Jain, J. Pharm. Pharm. Sci. 10, 86 (2007).
4. Q. Gan, T.Wang, C. Cochrane and P.McCarron, Colloids Surfaces B: Biointerfaces 44, 65 (2005).
5. A. Jintapattanakit, V. B. Junyaprasert, S. Mao, J. Sitterberg, U. Bakowsky and T. Kissel, Int. J. Pharm. 342, 240 (2007).
6. W. Sun, S. Mao, D. Mei and T. Kissel, Eur. J. Pharm. Biopharm. 69, 417 (2008).
7. M. Prabaharan and J. F. Mano, Drug. Deliv. 12, 41 (2005).
8. A. A. Salyers and M. O'Brien, J. Bacteriol. 143, 772 (1980).
9. W. B. Chen, L. F. Wang, J. S. Chen and S. Y. Fan, J. Biomed. Mater. Res. A 75, 128 (2005).
10. E. I. Sega and P. S. Low, Cancer Metastasis Rev. 27, 655 (2008).
11. P. S. Low, W. A. Henne and D. D. Doorneweerd, Acc. Chem. Res. 41, 120 (2008).
12. T. Islam and L. Josephson, Cancer Biomark. 5, 99 (2009).
13. C. P. Leamon, Curr. Opin. Invest. Drugs 9, 1277 (2008).
14. A. R. Hilgenbrink and P. S. Low, J. Pharm. Sci. 94, 2135 (2005).
15. H. S. Yoo and T. G. Park, J. Control. Rel. 100, 247 (2004).
16. H. C. de Oliveira, J. L. Fonseca and M. R. Pereira, J. Biomater. Sci. Polymer Edn 19, 143 (2008).
17. S. H. Kim, J. H. Jeong, C. O. Joe and T. G. Park, J. Control. Rel. 103, 625 (2005).
18. Y. Lu and P. S. Low, Adv. Drug Deliv. Rev. 54, 675 (2002).
19. P. Chan, M. Kurisawa, J. E. Chung and Y. Y. Yang, Biomaterials 28, 540 (2007).
20. S. Mansouri, Y. Cuie, F. Winnik, Q. Shi, P. Lavigne, M. Benderdour, E. Beaumont and J. C. Fernandes, Biomaterials 27, 2060 (2006).
21. M. L. Tan, A. M. Friedhuber, D. E. Dunstan, P. F. Choong and C. R. Dass, Biomaterials 31, 541 (2010).
22. J. Zhou, G. Wang, L. H. Zhang and X. S. Ye, Med. Res. Rev. 27, 279 (2007).
23. A. Bast, G. R. Haenen, A. M. Bruynzeel and W. J. Van der Vijgh, Cardiovasc. Toxicol. 7, 154 (2007).
24. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert and M. Ranson, Br. J. Cancer 90, 2085 (2004).
25. W. J. Deng, X. Q. Yang, Y. J. Liang, L. M. Chen, Y. Y. Yan, X. T. Shuai and L. W. Fu, Acta Pharmacol. Sin. 28, 913 (2007).
26. M. D. Chavanpatil, A. Khdair and J. Panyam, Pharm. Res. 24, 803 (2007).
27. H. L. Wong, R. Bendayan, A. M. Rauth and X. Y. Wu, J. Control. Rel. 116, 275 (2006).
28. I. A. Alsarra, S. S. Betigeri, H. Zhang, B. A. Evans and S. H. Neau, Biomaterials 23, 3637 (2002).
29. Y. S. Peng, S. C. Lin, S. J. Huang, Y. M.Wang, Y. J. Lin, L. F.Wang and J. S. Chen, Eur. J. Pharm. Sci. 29, 60 (2006).
30. S. J. Huang, S. L. Sun, T. H. Feng, K. H. Sung, W. L. Lui and L. F. Wang, Eur. J. Pharm. Sci. 38, 64 (2009).
31. M. Huang, Z. Ma, E. Khor and L. Y. Lim, Pharm. Res. 19, 1488 (2002).
32. S. W. Provencher, Comput. Phys. Commun. 27, 229 (1982).
33. R. Sachl, M. Uchman, P. Matejicek, K. Prochazka, M. Stepanek and M. Spirkova, Langmuir 23, 3395 (2007).
34. T. Mosmann, J. Immunol. Methods 65, 55 (1983).
35. T. Kurosaki, T. Kitahara, S. Kawakami, K. Nishida, J. Nakamura, M. Teshima, H. Nakagawa, Y. Kodama, H. To and H. Sasaki, Biomaterials 30, 4427 (2009).
36. M. Huang, E. Khor and L. Y. Lim, Pharm. Res. 21, 344 (2004).
37. J. Zhang, X. G. Chen, W. B. Peng and C. S. Liu, Nanomedicine 4, 208 (2008).
38. J. Zhang, X. G. Chen, Y. Y. Li and C. S. Liu, Nanomedicine 3, 258 (2007).
39. N. Ram, S. Aroui, E. Jaumain, H. Bichraoui, K. Mabrouk, M. Ronjat, H. Lortat-Jacob and M. de Waard, J. Biol. Chem. 283, 24274 (2008).
40. P. H. Weigel and J. H. Yik, Biochim. Biophys. Acta 1572, 341 (2002).
41. V. Kansara, D. Paturi, S. Luo, R. Gaudana and A. K. Mitra, Int. J. Pharm. 355, 210 (2008).
42. I. J. Majoros, A. Myc, T. Thomas, C. B. Mehta and J. R. Baker Jr., Biomacromolecules 7, 572 (2006).